Michael W Ronellenfitsch
Overview
Explore the profile of Michael W Ronellenfitsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dive I, Hahnefeld L, Wenger K, Kogel D, Steinbach J, Geisslinger G, et al.
Mol Oncol
. 2025 Feb;
PMID: 39992790
Glioblastoma (GB) is the most aggressive primary brain tumor with poor prognosis despite multimodal therapy. Calorie-restricted diets have emerged as putative strategies to augment anticancer therapies. We employed UHPLC-high-resolution mass...
2.
Le Rhun E, Bink A, Felsberg J, Gramatzki D, Brandner S, Benhamida J, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39842935
Background: Diffuse hemispheric glioma, histone 3 (H3) G34-mutant, has been newly defined in the 2021 WHO classification of central nervous system tumors. Here we sought to define the prognostic roles...
3.
Klinsing S, Beck J, Weber K, Bornemann-Kolatzki K, Dettki M, Urban H, et al.
Acta Neuropathol Commun
. 2024 Nov;
12(1):177.
PMID: 39568088
The gold standard for precise diagnostic classification of brain tumors requires tissue sampling, which carries relevant procedural risks. Brain biopsies often have limited sensitivity and fail to address tumor heterogeneity,...
4.
Sauer B, Kueckelhaus J, Lorenz N, Bozkurt S, Schulte D, Weinem J, et al.
Clin Transl Med
. 2024 Nov;
14(11):e70030.
PMID: 39552019
Glioblastoma, the most frequent primary malignant brain tumour in adults, is characterised by profound yet dynamic hypoxia and nutrient depletion. To sustain survival and proliferation, tumour cells are compelled to...
5.
Alcicek S, Pilatus U, Manzhurtsev A, Weber K, Ronellenfitsch M, Steinbach J, et al.
J Neurooncol
. 2024 Aug;
170(2):451-461.
PMID: 39192067
Purpose: Reprogramming of amino acid metabolism is relevant for initiating and fueling tumor formation and growth. Therefore, there has been growing interest in anticancer therapies targeting amino acid metabolism. While...
6.
Konig S, Strassheimer F, Brandner N, Schroder J, Urban H, Harwart L, et al.
Cell Death Discov
. 2024 Aug;
10(1):379.
PMID: 39187509
In glioblastoma (GB) cells oxidative stress is induced by both, conditions of the tumor microenvironment as well as by therapeutic interventions. Upregulation of superoxide dismutase 1 (SOD1), a key enzyme...
7.
Harter P, Weber K, Ricklefs F, Drexler R, Schuller U, Hack M, et al.
Neurooncol Adv
. 2024 Aug;
6(1):vdae138.
PMID: 39184173
No abstract available.
8.
Alcicek S, Dive I, Thomas D, Prinz V, Forster M, Czabanka M, et al.
J Magn Reson Imaging
. 2024 May;
61(1):426-438.
PMID: 38722043
Background: Emerging evidence suggests that fasting could play a key role in cancer treatment. Its metabolic effects on gliomas require further investigation. Purpose: To design a multi-voxel H/P MR-spectroscopic imaging...
9.
Zhao K, Braun M, Meyer L, Otte K, Raifer H, Helmprobst F, et al.
Cells
. 2024 Apr;
13(7.
PMID: 38607071
Adjuvant treatment for Glioblastoma Grade 4 with Temozolomide (TMZ) inevitably fails due to therapeutic resistance, necessitating new approaches. Apoptosis induction in GB cells is inefficient, due to an excess of...
10.
Rickel J, Zeeb D, Knake S, Urban H, Konczalla J, Weber K, et al.
Neurol Res Pract
. 2024 Apr;
6(1):19.
PMID: 38570823
Objective: Brain tumors and metastases account for approximately 10% of all status epilepticus (SE) cases. This study described the clinical characteristics, treatment, and short- and long-term outcomes of this population....